Location History:
- Mt. Prospect, IL (US) (1996 - 1998)
- LaFayette, CO (US) (2000)
Company Filing History:
Years Active: 1996-2000
Title: The Innovations of Jeffery Alan Zablocki
Introduction
Jeffery Alan Zablocki is a notable inventor based in Mt. Prospect, Illinois. He has made significant contributions to the field of radiopharmaceuticals, holding three patents to his name. His work focuses on developing innovative solutions for medical imaging and therapy.
Latest Patents
Zablocki's latest patents include a radiopharmaceutical composition capable of localizing at sites of thrombus containing activated platelets within a mammalian body. This invention features a linear peptidomimetic containing a ligand that specifically binds to the GPIIb/IIIa integrin receptor of platelets in the thrombus. The radiopharmaceutical is designed to be complexed with a selected metal radionuclide, allowing for both diagnostic imaging and therapeutic applications. The methods outlined in his patents provide effective ways to image thrombus sites and deliver targeted therapy, along with kits for preparing these radiopharmaceutical compositions.
Career Highlights
Zablocki has had a distinguished career at G.D. Searle & Company, where he has been instrumental in advancing the field of radiopharmaceuticals. His innovative work has contributed to the development of new diagnostic and therapeutic options in medicine.
Collaborations
Throughout his career, Zablocki has collaborated with notable colleagues, including Daniel L. Flynn and Robert B. Garland. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Jeffery Alan Zablocki's contributions to the field of radiopharmaceuticals exemplify the impact of innovation in medical science. His patents and collaborative efforts continue to pave the way for advancements in diagnostic and therapeutic techniques.